SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk of diabetic ketoacidosis

2015-06-26T11:20:12+01:00

Test for raised ketones in patients with acidosis symptoms, even if plasma glucose levels are near-normal.